Matias Ezequiel Gutierrez Suburu
University of Münster
11 Papers
10 Citations
Matias Ezequiel Gutierrez Suburu is an academic researcher from University of Münster. The author has contributed to research in topics: Phosphorescence & Chemistry. The author has an hindex of 3, co-authored 5 publications.
Author Tools
Chat about Author
Papers
Ligand-controlled and nanoconfinement-boosted luminescence employing Pt(II) and Pd(II) complexes: from color-tunable aggregation-enhanced dual emitters towards self-referenced oxygen reporters
Iván Maisuls,Cui Wang,Cui Wang,Matias Ezequiel Gutierrez Suburu,Sebastian Wilde,Constantin G. Daniliuc,Dana Brünink,Nikos L. Doltsinis,Stefan Ostendorp,Gerhard Wilde,Jutta Kösters,Ute Resch-Genger,Cristian A. Strassert +12 more
TL;DR: This supramolecular approach provides an elegant way to enable room-temperature phosphorescence from Pd(ii) complexes, which are otherwise quenched by a thermal population of dissociative states due to a lower ligand field splitting.
Mixed-ligand lanthanide complexes supported by ditopic bis(imino-methyl)-phenol/calix[4]arene macrocycles: synthesis, structures, and luminescence properties of [Ln2(L2)(MeOH)2] (Ln = La, Eu, Tb, Yb).
Steve Ullmann,Peter Hahn,Parvathy Mini,Kellie L. Tuck,Axel Kahnt,Bernd Abel,Bernd Abel,Matias Ezequiel Gutierrez Suburu,Cristian A. Strassert,Berthold Kersting +9 more
TL;DR: The ratio α = K11/K21 of the stepwise formation constants for the mononuclear and dinuclear complexes was found to be invariably smaller than unity indicating that the binding of the first Ln3+ ion augments thebinding of the second Ln 3+ ion.
Electrostatic anti-CD33-antibody–protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia
Nicole Bäumer,Annika Scheller,Lisa Wittmann,Andreas Faust,M. Apel,Subbaiah Chary Nimmagadda,Christiane Geyer,Katharina Grunert,Neele Kellmann,Matthias Peipp,Sareetha Kailayangiri,Matias Ezequiel Gutierrez Suburu,Cristian A. Strassert,Mathias Schenk,Lilo Greune,Christian Rüter,Petra Dersch,Wolfgang Hartmann,Claudia Rossig,Dario Neri,Carsten Müller-Tidow,Christian Schwöppe,Christoph Schliemann,Cyrus Khandanpour,Georg Lenz,Wolfgang E. Berdel,Sebastian Bäumer +26 more
TL;DR: In this article , the authors presented a new experimental platform technology of molecular oncogene targeting in acute myeloid leukemia (AML), which consists of an internalizing anti-CD33-antibody-protamine conjugate, which together with anionic molecules such as siRNA oribrutinib-Cy3.5 and cationic free protamine spontaneously assembles into vesicular nanocarriers in aqueous solution.